Current otolaryngologic applications of the novel self-assembling RADA-16 peptide matrix.
Laryngoscope Investig Otolaryngol
; 9(4): e1299, 2024 Aug.
Article
em En
| MEDLINE
| ID: mdl-39015551
ABSTRACT
A novel bioresorbable agent on the market is PuraGel® (3-D Matrix, Tokyo, Japan), a RADA-16 product that acts as a synthetic hemostatic and space-filling gel that promotes wound healing and prevents adhesion formation. Given the reported benefits of accelerated wound healing and scar tissue prevention, there are multiple otolaryngologic applications where RADA-16 might improve outcomes. Our study highlights current utilization and associated post-operative complications with this product.
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Revista:
Laryngoscope Investig Otolaryngol
Ano de publicação:
2024
Tipo de documento:
Article